breast cancer

Open Access
Human Epidermal Growth Factor Receptor 2–Targeting [⁶⁸Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer
Ali Alhuseinalkhudhur, Henrik Lindman, Per Liss, Tora Sundin, Fredrik Y. Frejd, Johan Hartman, Victor Iyer, Joachim Feldwisch, Mark Lubberink, Caroline Rönnlund, Vladimir Tolmachev, Irina Velikyan and Jens Sörensen

Journal of Nuclear Medicine September 1, 2023, 64 (9) 1364-1370; DOI: https://doi.org/10.2967/jnumed.122.265364
You have access
Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly

Journal of Nuclear Medicine August 31, 2023, jnumed.123.265853; DOI: https://doi.org/10.2967/jnumed.123.265853
You have access
Initial Results of ⁶⁸Ga-FAPI-46 PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
Philipp Backhaus, Matthias C. Burg, Inga Asmus, Michaela Pixberg, Florian Büther, Hans-Jörg Breyholz, Randy Yeh, Stefanie B. Weigel, Patricia Stichling, Walter Heindel, Stefanie Bobe, Peter Barth, Joke Tio and Michael Schäfers

Journal of Nuclear Medicine May 1, 2023, 64 (5) 717-723; DOI: https://doi.org/10.2967/jnumed.122.264871
You have access
Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on ¹⁸F-FDG PET/MRI and Machine Learning
Janna Morawitz, Benjamin Sigl, Christian Rubbert, Nils-Martin Bruckmann, Frederic Dietzel, Lena J. Häberle, Saskia Ting, Svjetlana Mohrmann, Eugen Ruckhäberle, Ann-Kathrin Bittner, Oliver Hoffmann, Pascal Baltzer, Panagiotis Kapetas, Thomas Helbich, Paola Clauser, Wolfgang P. Fendler, Christoph Rischpler, Ken Herrmann, Benedikt M. Schaarschmidt, Andreas Stang, Lale Umutlu, Gerald Antoch, Julian Caspers and Julian Kirchner

Journal of Nuclear Medicine February 1, 2023, 64 (2) 304-311; DOI: https://doi.org/10.2967/jnumed.122.264138
You have access
Improved Tumor Responses with Sequential Targeted α-Particles Followed by Interleukin 2 Immunocytokine Therapies in Treatment of CEA-Positive Breast and Colon Tumors in CEA Transgenic Mice
Megan Minnix, Maciej Kujawski, Erasmus Poku, Paul J. Yazaki, Jeffrey Y. Wong and John E. Shively

Journal of Nuclear Medicine December 1, 2022, 63 (12) 1859-1864; DOI: https://doi.org/10.2967/jnumed.122.264126
Open Access
Use of ⁶⁴Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study
Joanne E. Mortimer, James R. Bading, Paul H. Frankel, Mary I. Carroll, Yuan Yuan, Jinha M. Park, Lusine Tumyan, Nikita Gidwaney, Erasmus K. Poku, John E. Shively and David M. Colcher

Journal of Nuclear Medicine August 1, 2022, 63 (8) 1145-1148; DOI: https://doi.org/10.2967/jnumed.121.262940
You have access
Biodistribution of ¹⁸F-FES in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (G1T48), a Novel Selective ER Degrader
Ramsha Iqbal, Maqsood Yaqub, Daniela E. Oprea-Lager, Yeukman Liu, Anne Marije Luik, Andy P. Beelen, Robert C. Schuit, Albert D. Windhorst, Ronald Boellaard and Catharina W. Menke-van der Houven van Oordt

Journal of Nuclear Medicine May 1, 2022, 63 (5) 694-699; DOI: https://doi.org/10.2967/jnumed.121.262500
You have access
Imaging Androgen Receptors in Breast Cancer with ¹⁸F-Fluoro-5α-Dihydrotestosterone PET: A Pilot Study
Heather Jacene, Mofei Liu, Su-Chun Cheng, Amanda Abbott, Shipra Dubey, Keisha McCall, Diane Young, Mayzie Johnston, Annick D. Van den Abbeele and Beth Overmoyer

Journal of Nuclear Medicine January 1, 2022, 63 (1) 22-28; DOI: https://doi.org/10.2967/jnumed.121.262068
You have access
Determining the Axillary Nodal Status with 4 Current Imaging Modalities, Including ¹⁸F-FDG PET/MRI, in Newly Diagnosed Breast Cancer: A Comparative Study Using Histopathology as the Reference Standard
Janna Morawitz, Nils-Martin Bruckmann, Frederic Dietzel, Tim Ullrich, Ann-Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Lena Häberle, Marc Ingenwerth, Lale Umutlu, Wolfgang Peter Fendler, Tanja Fehm, Ken Herrmann, Gerald Antoch, Lino Morris Sawicki and Julian Kirchner

Journal of Nuclear Medicine December 1, 2021, 62 (12) 1677-1683; DOI: https://doi.org/10.2967/jnumed.121.262009
You have access
Value of ¹⁸F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
Jorianne Boers, Naila Loudini, Celina L. Brunsch, Sylvia A. Koza, Erik F.J. de Vries, Andor W.J.M. Glaudemans, Geke A.P. Hospers and Carolina P. Schröder

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1214-1220; DOI: https://doi.org/10.2967/jnumed.120.256826

Main menu

User menu

Search

breast cancer

Pages